Published in Environ Health Perspect on October 01, 1993
Revised methods for the Salmonella mutagenicity test. Mutat Res (1983) 11.60
Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids. Pharmacol Rev (1973) 1.53
Mutagens-carcinogens in foods. Cancer Res (1983) 1.31
The metabolic activation of carcinogenic aromatic amines and amides. Prog Exp Tumor Res (1969) 1.23
Induction of gene mutation in and cell transformation of mammalian cells by modified purines: 2-aminopurine and 6-N-hydroxylaminopurine. Proc Natl Acad Sci U S A (1981) 1.16
Biochemical studies on the mutagen, 6-N-hydroxylaminopurine. Synthesis of the deoxynucleoside triphosphate and its incorporation into DNA in vitro. J Biol Chem (1986) 1.03
Hepatic microsomal N-hydroxylation of adenine to 6-N-hydroxylaminopurine. Biochem Pharmacol (1990) 0.98
The mutagenic effect of hydroxyaminopurine derivatives on phage T4. Mutat Res (1968) 0.97
Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. Crit Rev Toxicol (1986) 0.96
N-hydroxylation of carcinogenic and mutagenic aromatic amines. Environ Health Perspect (1983) 0.90
A comparison of the oncogenicities of 3-hydroxyxanthine, guanine 3-N-oxide, and some related compounds. Cancer Res (1970) 0.84
Transversion-specific purine analogue mutagens and the mechanism of hydroxylaminopurine mutagenesis. Mutat Res (1987) 0.81
Teratogenic effects of 6-hydroxylaminopurine in the rat--protection by inosine. Biochem Pharmacol (1969) 0.80
Carcinogenic N-hydroxylaminopurine derivatives do not act as base analog mutagens in Salmonella typhimurium. Mutat Res (1985) 0.78
Biological N-oxidation of adenine and 9-alkyl derivatives. Eur J Drug Metab Pharmacokinet (1988) 0.78
Studies on the in vitro biological N-oxidation of trimethoprim. Eur J Drug Metab Pharmacokinet (1988) 0.78
Metabolic N-oxygenation of 2,4-diamino-6-substituted pyrimidines. Eur J Drug Metab Pharmacokinet (1988) 0.78
Conformational analysis of 9-substituted adenines in relation to their microsomal N1-oxidation. J Pharm Pharmacol (1989) 0.78
Mutagenicity of derivatives of the oncogenic purine N-oxides. Cancer Res (1974) 0.78
Purine N-oxides. XVI. Oncogenic derivatives of xanthine and guanine. Cancer Res (1965) 0.78
SOME INHIBITORY PROPERTIES OF 6-N-HYDROXYLAMINOPURINE: AN ANALOG OF ADENINE AND HYPOXANTHINE. Biochem Pharmacol (1964) 0.78
Oncogenic purine N-oxide derivatives as substrates for sulfotransferase. Cancer Res (1973) 0.78
REM sleep behaviour disorder in Hong Kong Chinese: clinical outcome and gender comparison. J Neurol Neurosurg Psychiatry (2008) 1.76
Spinal instability and the log-rolling maneuver. J Trauma (1987) 1.52
Familial aggregation and heritability of insomnia in a community-based study. Sleep Med (2012) 1.46
Young-onset REM sleep behavior disorder: Beyond the antidepressant effect. Sleep Med (2011) 1.42
A prospective toxicity evaluation (COMPACT) on 40 chemicals currently being tested by the National Toxicology Program. Mutagenesis (1990) 1.37
Validation of a new REM sleep behavior disorder questionnaire (RBDQ-HK). Sleep Med (2009) 1.27
Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. Biochem Pharmacol (1987) 1.22
Loneliness, health and depression in older males. Aging Ment Health (2003) 1.18
A retrospective evaluation of COMPACT predictions of the outcome of NTP rodent carcinogenicity testing. Environ Health Perspect (1995) 1.15
COMPACT and molecular structure in toxicity assessment: a prospective evaluation of 30 chemicals currently being tested for rodent carcinogenicity by the NCI/NTP. Environ Health Perspect (1996) 1.02
A cluster of meningococcal disease in western Sydney, Australia initially associated with a nightclub. Epidemiol Infect (1998) 1.01
Complement activation within the coeliac small intestine is localised to Brunner's glands. Gut (1989) 1.01
CT findings in osteoradionecrosis of the mandible. Skeletal Radiol (1996) 0.98
Peritonitis associated with a CDC group EO-3 organism. J Clin Microbiol (1997) 0.96
Interaction of a series of nitriles with the alcohol-inducible isoform of P450: computer analysis of structure-activity relationships. Xenobiotica (1994) 0.93
The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance. Eur Heart J (1987) 0.92
Long-term outcomes and predictors of chronic insomnia: a prospective study in Hong Kong Chinese adults. Sleep Med (2012) 0.92
Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes. Biochem J (1990) 0.91
Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+. Proc Natl Acad Sci U S A (1989) 0.91
Organic nitrate reductase: reassessment of its subcellular localization and tissue distribution and its relationship to the glutathione transferases. Int J Biochem (1989) 0.91
The 1990 Pharmaceutical Manufacturers Association of Canada keynote lecture. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals. Can J Physiol Pharmacol (1991) 0.91
Molecular dimensions of the substrate binding site of cytochrome P-448. Biochem Pharmacol (1986) 0.90
Sex is an important variable affecting spontaneous micronucleus frequency in cytokinesis-blocked lymphocytes. Mutat Res (1994) 0.90
Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates. J Pharm Pharmacol (1975) 0.90
Cytochromes P450 and species differences in xenobiotic metabolism and activation of carcinogen. Environ Health Perspect (1998) 0.90
Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rat. Eur J Pharmacol (1995) 0.90
Selective induction of rat hepatic CYP1 and CYP4 proteins and of peroxisomal proliferation by green tea. Carcinogenesis (1994) 0.89
Spectral and kinetic studies of the interaction of imidazole anti-fungal agents with microsomal cytochromes P-450. Xenobiotica (1987) 0.88
Induction of hepatic CYP1A2 by the oral administration of caffeine to rats: lack of association with the Ah locus. Biochim Biophys Acta (1995) 0.88
Interrater and intrarater reliability in multiple sleep latency test. J Clin Neurophysiol (2008) 0.87
Flavimonas oryzihabitans infection of a surgical wound. Pathology (1990) 0.86
Polyadenylic acid polymerase activity in normal and leukemic human leukocytes. Cancer Res (1984) 0.85
Microbiological aspects of an outbreak of Legionnaires' disease in south western Sydney. Pathology (1994) 0.85
HomeChoice automated peritoneal dialysis machines: the impact of reuse of tubing and cassettes. Perit Dial Int (2000) 0.85
Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm Res (1998) 0.85
External quality assurance of molecular analysis of haemochromatosis gene mutations. J Clin Pathol (2006) 0.84
An examination of DNA strand breakage in the comet assay and antioxidant capacity in diabetic patients. Mutat Res (1998) 0.84
Guiding BMP adoption to improve water quality in various estuarine ecosystems in Western Australia. Water Sci Technol (2008) 0.84
Apicoectomy on molars: a clinical and radiographical study. Int J Oral Surg (1983) 0.84
Modulation of the rat hepatic cytochrome P450 composition by long-term streptozotocin-induced insulin-dependent diabetes. J Biochem Toxicol (1994) 0.83
Molecular modelling of cytochrome CYP1A1: a putative access channel explains differences in induction potency between the isomers benzo(a)pyrene and benzo(e)pyrene, and 2- and 4-acetylaminofluorene. Toxicol Lett (1994) 0.83
The metabolism of alicyclic amines to reactive iminium ion intermediates. Eur J Drug Metab Pharmacokinet (1995) 0.82
Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450. Food Cosmet Toxicol (1981) 0.82
Cytochrome P-450-dependent mixed-function oxidase and glutathione S-transferase activities in spontaneous obesity-diabetes. Biochem Pharmacol (1992) 0.82
Nitrosamine carcinogenesis: rodent assays, quantitative structure-activity relationships, and human risk assessment. Drug Metab Rev (1997) 0.82
Effect of cataract extraction on frequency doubling technology perimetry in patients with glaucoma. Br J Ophthalmol (2005) 0.82
Bioactivation of the mushroom hydrazine, agaritine, to intermediates that bind covalently to proteins and induce mutations in the Ames test. Carcinogenesis (1997) 0.81
Induction of hepatic microsomal CYP4A activity and of peroxisomal beta-oxidation by two non-steroidal anti-inflammatory drugs. Arch Toxicol (1994) 0.81
Mutagenicity of bay-region amino-substituted cyclopenta[a]phenanthrenes and 2- and 5-aminochrysene. Mutat Res (2001) 0.81
Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica (1999) 0.81
Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes. Environ Mol Mutagen (1992) 0.81
An evaluation of the in vitro activity of piperacillin/tazobactam. Pathology (1996) 0.81
Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochromes P-450. Toxicology (1988) 0.81
Interaction with the aromatic hydrocarbon receptor, CYP1A induction, and mutagenicity of a series of diaminotoluenes: implications for their carcinogenicity. Toxicol Appl Pharmacol (1996) 0.81
Structural requirements for substrates of cytochromes P-450 and P-448. Chem Biol Interact (1987) 0.81
The role of highly purified forms of rat liver cytochrome P-450 in the dimethylation of dimethylnitrosamine and its activation to mutagens. Toxicol Lett (1983) 0.80
Role of cytochromes P-450 in mouse liver tumor production. Prog Clin Biol Res (1990) 0.80
Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease. Eur Heart J (1987) 0.80
Inhibition of rat hepatic mixed function oxidases by antimalarial drugs: selectivity for cytochromes P-450 and P-448. Chem Biol Interact (1984) 0.80
Consumption of tea modulates the urinary excretion of mutagens in rats treated with IQ. Role of caffeine. Mutat Res (1999) 0.80
Stimulation of rat hepatic UDP-glucuronosyl transferase activity following treatment with green tea. Food Chem Toxicol (1995) 0.80
Tissue differences in the modulation of rat cytochromes P450 and phase II conjugation systems by dietary doses of phenethyl isothiocyanate. Food Chem Toxicol (2008) 0.80
Proliferation of hepatic peroxisomes in rats following the intake of green or black tea. Toxicol Lett (1999) 0.80
Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test. Mutat Res (1992) 0.80
The mutagenic and cell transforming properties of shikimic acid and some of its bacterial and mammalian metabolites. Toxicol Lett (1984) 0.80
A comparison of the protective effects of N-acetyl-cysteine and S-carboxymethylcysteine against paracetamol-induced hepatotoxicity. Toxicology (1983) 0.80
Inhibition of the mutagenicity of aromatic amines by the plant flavonoid (+)-catechin. Cancer Res (1985) 0.79
A retrospective study of the molecular toxicology of benoxaprofen. Toxicology (1990) 0.79
Prediction of chemical carcinogenicity from molecular and electronic structures: a comparison of MINDO/3 and CNDO/2 molecular orbital methods. Toxicol Lett (1989) 0.79
Agaritine does not mediate the mutagenicity of the edible mushroom Agaricus bisporus. Mutagenesis (1991) 0.79
Induction of rat hepatic mixed-function oxidases by acetone and other physiological ketones: their role in diabetes-induced changes in cytochrome P450 proteins. Xenobiotica (1992) 0.79
Marked antimutagenic potential of aqueous green tea extracts: mechanism of action. Mutagenesis (1994) 0.79
The role of nutrition in toxicology. Annu Rev Nutr (1981) 0.79
Effect of syngeneic anti-idiotypic antibody on influenza virus neuraminidase antibody response. Viral Immunol (1987) 0.79
Activation of benzo(a)pyrene and 2-acetamidofluorene to mutagens by microsomal preparations from different animal species: role of cytochrome P-450 and P-448. Xenobiotica (1981) 0.79
Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity. Biochem Pharmacol (1992) 0.79
Mutagenicity of chrysene, its methyl and benzo derivatives, and their interactions with cytochromes P-450 and the Ah-receptor; relevance to their carcinogenic potency. Toxicology (1993) 0.78
Contribution of CYP1A2 in the hepatic metabolism of melatonin: studies with isolated microsomal preparations and liver slices. J Pineal Res (2001) 0.78
The metabolism and bioactivation of agaritine and of other mushroom hydrazines by whole mushroom homogenate and by mushroom tyrosinase. Toxicology (2001) 0.78
Enhancement of cell-mediated immunity in melanoma patients immunized with murine anti-idiotypic monoclonal antibodies (MELIMMUNE) that mimic the high molecular weight proteoglycan antigen. Clin Cancer Res (1998) 0.78
Contribution of theafulvins to the antimutagenicity of black tea: their mechanism of action. Mutagenesis (1998) 0.78
Extrahepatic expression of P450 proteins in insulin-dependent diabetes mellitus. Xenobiotica (1995) 0.78
Bioactivation of N-nitrosopiperidine to mutagens: role of hepatic cytochrome P-450 proteins and contribution of cytosolic fraction. Carcinogenesis (1987) 0.78
Contribution of caffeine and flavanols in the induction of hepatic Phase II activities by green tea. Food Chem Toxicol (1998) 0.78
Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins. Food Chem Toxicol (2003) 0.78
Molecular modeling of enzymes and receptors involved in carcinogenesis: QSARs and compact-3D. Drug Metab Rev (1994) 0.78
[Inter-individual testing of water-soluble oral contrast media with reference to their diagnostic value, side effects and taste]. Rontgenblatter (1989) 0.78
Role of tissue glutathione in prevention of surgical trauma. Xenobiotica (1993) 0.78
Induction of the cytochrome P450 I and IV families and peroxisomal proliferation in the liver of rats treated with benoxaprofen. Possible implications in its hepatotoxicity. Biochem Pharmacol (1991) 0.78
Drug metabolism in the ferret: effects of age, sex and strain. Gen Pharmacol (1977) 0.78
Effect of antioxidant flavonoids and a food mutagen on lymphocytes of a thalassemia patient without chelation therapy in the Comet assay. Teratog Carcinog Mutagen (2001) 0.78
Sex differences in the diabetes-induced modulation of rat hepatic cytochrome P450 proteins. Biochem Pharmacol (1993) 0.78
Expression and inducibility of cytochrome P450 proteins in the liver of chick embryo. Arch Toxicol (1996) 0.78
Mutagenicity and CYP1A induction by azobenzenes correlates with their carcinogenicity. Carcinogenesis (1994) 0.78
Metabolic and structural viability of precision-cut rat lung slices in culture. Xenobiotica (2004) 0.78
Inhibition of cytochrome P-448 mixed function oxidase activity following administration of 9-hydroxyellipticine to rats. Chem Biol Interact (1980) 0.78
Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences. Mutagenesis (1986) 0.77
Metabolic activation of paracetamol by highly purified forms of cytochrome P-450. Res Commun Chem Pathol Pharmacol (1983) 0.77